Preferred Label : Fedratinib;

MeSH note : a selective small-molecule inhibitor of JAK2;

CISMeF synonym : TG101348;

MeSH synonym : N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino) pyrimidin-4-ylamino)benzenesulfonamide;

MeSH hyponym : SAR-302503A; SAR302503A; SAR-302503; fedratinib hydrochloride monohydrate; fedratinib dihydrochloride monohydrate; N-tert-butyl-3-((5-methyl-2-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)pyrimidin-4-yl)amino) benzenesulfonamide dihydrochloride monohydrate; TG-101348;

Related MeSH term : SAR302503;

MeSH Related Number : UH9J2HBQWJ;

Is substance : O;

UNII : 6L1XP550I6;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3546943/fr/inrebic-fedratinib-splenomegalie-et-symptomes-de-la-myelofibrose
2024
false
false
false
France
treatment outcome
fedratinib
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
Post-Essential Thrombocythemia Myelofibrosis
insurance, health, reimbursement
administration, oral
evaluation of the transparency committee
splenomegaly
primary myelofibrosis
Fedratinib

---
https://www.has-sante.fr/jcms/p_3313612/fr/inrebic-fedratinib
2022
false
false
false
France
fedratinib hydrochloride
insurance, health, reimbursement
treatment outcome
adult
primary myelofibrosis
splenomegaly
fedratinib
Janus Kinase Inhibitors
JAK2 Inhibitor
Product containing precisely fedratinib (as fedratinib hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug)
evaluation of the transparency committee
Fedratinib
Inrebic

---
https://www.cadth.ca/fr/fedratinib
2021
false
false
false
Canada
French
drug information
Fedratinib
Inrebic
Product containing only fedratinib in oral dose form (medicinal product form)
pyrrolidines
sulfonamides

---
https://www.ema.europa.eu/en/medicines/human/EPAR/inrebic
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fedratinib
Fedratinib
drug approval
europe
fedratinib
adult
primary myelofibrosis
Myelofibrosis due to and following polycythemia vera (disorder)
Post-Essential Thrombocythemia Myelofibrosis
orphan drug production
administration, oral
Janus Kinase Inhibitors
Janus Kinase Inhibitors
JAK2 Inhibitor
drug monitoring
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Product containing precisely fedratinib (as fedratinib hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug)
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
pyrrolidines
sulfonamides
pyrrolidines
sulfonamides

---
Nous contacter.
25/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.